Fusion
Payments companies reported to CMS as associated with Fusion. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fusion, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fusion
These are the largest totals companies reported as associated with Fusion. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stephen Deal | Charlotte, NC | Gastroenterology (Internal Medicine) | $289,001.91 |
| Kenneth Chang | Newport Beach, CA | Gastroenterology (Internal Medicine) | $203,462.28 |
| Willis Parsons | Arlington Heights, IL | Gastroenterology (Internal Medicine) | $30,256.16 |
| Vijay Ramakrishnan | Aurora, CO | Otolaryngology | $27,378.04 |
| Vivek Kaul | Rochester, NY | Gastroenterology (Internal Medicine) | $24,473.15 |
| Glen Lehman | Indianapolis, IN | Gastroenterology (Internal Medicine) | $21,000.00 |
| Mark Gromski | Indianapolis, IN | Gastroenterology (Internal Medicine) | $14,679.13 |
| Abhitabh Patil | St Petersburg, FL | Gastroenterology (Internal Medicine) | $13,550.08 |
| Rijul Kshirsagar | Rochester, MN | Otolaryngology | $12,432.26 |
| Greg Davis | Puyallup, WA | Otolaryngology | $10,099.03 |
Prescribed Fusion?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.